Skip to content

COVID-19: Germany suspends AstraZeneca vaccine over blood clot concerns

Germany has become the biggest country in Europe to suspend the use of AstraZeneca’s COVID-19 vaccine following reports of dangerous blood clots in some recipients.

Germany’s health minister Jens Spahn described the move to suspend the use of AstraZeneca vaccine as a “precaution”.

Jens Spahn posted on Twitter: “Based on a current recommendation from the Paul Ehrlich Institute, the federal government is suspending the corona vaccinations (from) AstraZeneca as a precaution.”

“Following new reports of cerebral vein thrombosis in connection with the vaccination in Germany and Europe, the Paul Ehrlich Institute considers further investigations to be necessary.”

“The European Medicines Agency (EMA) will decide whether and how the new findings will affect the approval of the vaccine.”